Anthea Cherednichenko: Over 70 Years of Supporting Hemophilia and Bleeding Disorders at Takeda
Anthea Cherednichenko, Vice President, Franchise Head of Hematology and Transplant, USBU at Takeda, shared Takeda’s post on LinkedIn, adding:
”For over 70 years teams at Takeda have been supporting people living with hemophilia and bleeding disorders.
On WHD, I want to express my gratitude for all of these teams today, and over the years, for their commitment. And to the members of this community who inspire us, collaborate with us, and trust us to be part of your journey – thank you.
Your resilience, courage, and advocacy continue to drive progress and remind us why this work matters.
Together, we remain committed to advancing care, expanding possibilities, and helping create a better future for everyone affected by bleeding disorders.”
Takeda, shared a post on LinkedIn:
”A timely and accurate diagnosis is a critical first step in helping people living with hemophilia access the support and care they need.
Today on World Hemophilia Day, we join the global hemophilia community in recognizing the critical need for efforts that advance awareness and education to ultimately speed time to an accurate diagnosis.
This mission guides us as we engage with healthcare professionals, people with bleeding disorders and stakeholders from around the world at the World Federation of Hemophilia 2026 World Congress in Malaysia.
We look forward to discussing how to advance our shared goal of improving care for this community.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 14:54James Fildes: Modeling Device Related Thrombosis in Multi Organ Systems
-
Sep 25, 2026, 14:51Platelet Metabolic Reprogramming: How Cellular Energy Drives Thrombosis
-
Sep 25, 2026, 14:46Thomas Maxwell: From Hemophilia Shame to Strength – Walking for Bleeding Disorders
-
Sep 25, 2026, 14:35Sarita Rani Jaiswal: Sharing Basic Science Insights at EBMT HWP 2026
-
Sep 25, 2026, 14:12Managing Breakthrough Bleeds in Hemophilia – National Bleeding Disorders Foundation
-
Sep 25, 2026, 13:50Alejandro González Veliz: Beyond the Golden Hour in Stroke Care
-
Sep 25, 2026, 13:32Gevorg Yaghjyan: Low Drug Levels, Higher Cardiovascular Risk in Lupus
-
Sep 25, 2026, 12:53Bastu Odoka: What Happened to Blood Donation?
-
Sep 25, 2026, 12:43Thomas Dayspring: Reshaping the Biology of Atherosclerotic Plaques with New Therapies